Evidence map›Paper›PMID 33323329›Full record

ArticleWomen's health issues : official publication of the Jacobs Institute of Women's Health

Patients' Experiences with an Immediate Postpartum Long-Acting Reversible Contraception Program.

Cristina Wallace Huff, Joseph E Potter, Kristine Hopkins

Open access · greenAbstract read
In one paragraph

Article in Women's health issues : official publication of the Jacobs Institute of Women's Health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Effects of the immediate postpartum insertion of the etonogestrel implant on the development of breastfed infants: Results from a randomized controlled trial.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Use of postpartum contraception during coronavirus disease 2019 (COVID-19): A retrospective cohort study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021
    Article
  8. Article
  9. Satisfaction, Resignation, and Dissatisfaction with Long-Acting Reversible Contraception among Low-Income Postpartum Texans.Women's health issues : official publication of the Jacobs Institute of Women's Health
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Cristina Wallace HuffDepartment of Obstetrics and Reproductive Sciences, University of Texas Health Science Center at San Antonio, San Antonio, Texas. Electronic address: wallacehuff@uthscsa.edu.
Joseph E PotterPopulation Research Center and Texas Policy Evaluation Project, The University of Texas at Austin, Austin, Texas.
Kristine HopkinsPopulation Research Center and Texas Policy Evaluation Project, The University of Texas at Austin, Austin, Texas.
The University of Texas at Austin · USThe University of Texas Health Science Center at San Antonio · US

Funding

Population Research CenterR24HD042849 · NICHD · UNIVERSITY OF TEXAS AUSTIN · PI UMBERSON, DEBRA J. · 2002 to 2016
$8.4M
Scientific & Technical CoreP2CHD042849 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI MARK D. HAYWARD · 2017 to 2026
$5.2M
NICHD NIH HHS P2C HD042849NICHD NIH HHS R24 HD042849
6 · The paper itself

Abstract

introductionWe compared the characteristics of postpartum women who recalled being offered or not offered intrauterine devices and implants and who obtained placement of these long-acting reversible contraceptive (LARC) devices at a county hospital before discharge. We assessed satisfaction and continuation among those who obtained LARC methods.

methodsWe interviewed 199 patients who delivered at a Texas hospital and tested for differences in who recalled being offered/not offered immediate postpartum LARC. We provide descriptive statistics on when offered and satisfaction, and assess continuation using Kaplan-Meier survival curves.

resultsThere were 103 of 199 women (51.8%) who recalled providers offering them immediate postpartum LARC; English-speaking relative to Spanish-speaking Hispanic women had higher odds of recounting being offered immediate postpartum LARC (adjusted odds ratio [OR], 3.88; 95% confidence interval [CI], 1.33-11.23), as did women with two children versus one child (OR, 3.64; 95% CI, 1.13-11.67). Compared with women 18-24 years of age who wanted more children, women 30-34 years of age who wanted more children had lower odds (OR, 0.14; 95% CI, 0.03-0.59), as did sterilized women 18 to 44 (OR, 0.02; 95% CI, 0.00-0.10). Seventy-four women (37% of all and 72% of those who recalled being offered) received immediate postpartum LARC. Sixty percent of those who received immediate postpartum LARC recalled that they were first offered it during prenatal care. Satisfaction was high but decreased between 3 and 6 months postpartum, mainly owing to negative side effects. Continuation at 24 months postpartum was 76.9% (CI, 71.7%-81.4%), with no difference between intrauterine device and implant use.

conclusionsLanguage barriers may have hindered equal access to immediate postpartum LARC for Spanish-speaking patients; younger patients were more likely to recall being offered immediate postpartum LARC, possibly owing to providers' implicit biases or greater demand for LARC versus sterilization. Using formal interpretation services and patient-centered decision making may improve patient access to the contraception methods most aligned with their values and preferences.

Indexed as

Contraceptive Agents, FemaleIntrauterine DevicesLong-Acting Reversible ContraceptionAdultChildContraceptionFemaleHumansPostpartum PeriodPregnancyTexasContraceptive Agents, Female

Identifiers

PMID33323329
PMCPMC8005445
OpenAlexW3112382411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.